Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study-Reference-Cited by-同舟云学术

Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study

Published:2014-08 Issue:9 Volume:15 Page:931-942
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Sant Milena,Minicozzi Pamela,Mounier Morgane,Anderson Lesley A,Brenner Hermann,Holleczek Bernd,Marcos-Gragera Rafael,Maynadié Marc,Monnereau Alain,Osca-Gelis Gemma,Visser Otto,De Angelis Roberta

Publisher

Elsevier BV

Subject

Oncology

Reference33 articles.

1. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma;Coiffier;N Engl J Med,2002

2. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia;Plosker;Drugs,2003

3. Monoclonal antibody therapy with rituximab for acute lymphoblastic leukemia;Thomas;Hematol Oncol Clin North Am,2009

4. Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia;O'Brien;N Engl J Med,2003

5. The emerging role of targeted therapy for hematologic malignancies: update on bortezomib and tipifarnib;Armand;Oncologist,2007

Cited by 235 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative effectiveness of 6x R-CHOP21 versus 6x R-CHOP21 + 2 R for patients with advanced-stage diffuse large B-cell lymphoma;Blood Cancer Journal;2024-09-12

2. A metric for comparison and visualization of age disparities in cancer survival;Cancer Epidemiology;2024-08

3. Disparities in mortality risk after diagnosis of hematological malignancies in 185 countries: A global data analysis;Cancer Letters;2024-07

4. Multiple myeloma;Nature Reviews Disease Primers;2024-06-27

5. Aligning outcomes: DLBCL prognosis at a 4th Level University Hospital in Bogotá is comparable to high-income nations, identification of additional prognostic markers for overall survival and relapse;ecancermedicalscience;2024-06-20